4 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 10 points (0.1%) at 14,085 as of Thursday, Feb. 28, 2013, 12:04 PM ET. The NYSE advances/declines ratio sits at 1,607 issues advancing vs. 1,243 declining with 160 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Fresenius Medical Care Corporation ( FMS), up 0.8%. A company within the industry that increased today was DaVita HealthCare Partners ( DVA), up 1.4%.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:

4. Cigna ( CI) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.26 (-0.4%) to $58.72 on light volume Thus far, 601,373 shares of Cigna exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $58.18-$59.03 after having opened the day at $58.92 as compared to the previous trading day's close of $58.98.

CIGNA Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $16.5 billion and is part of the health care sector. The company has a P/E ratio of 9.7, below the S&P 500 P/E ratio of 17.7. Shares are up 10.3% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Cigna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, attractive valuation levels, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cigna Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

3. As of noon trading, Thermo Fisher Scientific ( TMO) is down $0.32 (-0.4%) to $73.93 on light volume Thus far, 712,992 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $73.77-$74.89 after having opened the day at $74.42 as compared to the previous trading day's close of $74.25.

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $26.4 billion and is part of the health care sector. The company has a P/E ratio of 21.4, above the S&P 500 P/E ratio of 17.7. Shares are up 16.4% year to date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Thermo Fisher Scientific Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, Humana ( HUM) is down $0.50 (-0.7%) to $68.72 on average volume Thus far, 995,940 shares of Humana exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $68.01-$69.50 after having opened the day at $69.14 as compared to the previous trading day's close of $69.21.

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. Humana has a market cap of $10.9 billion and is part of the health care sector. The company has a P/E ratio of 9.2, below the S&P 500 P/E ratio of 17.7. Shares are up 0.8% year to date as of the close of trading on Wednesday. Currently there are 15 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Humana Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, Aetna ( AET) is down $0.09 (-0.2%) to $47.44 on average volume Thus far, 1.4 million shares of Aetna exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $46.91-$47.58 after having opened the day at $47.50 as compared to the previous trading day's close of $47.53.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $15.3 billion and is part of the health care sector. The company has a P/E ratio of 9.7, below the S&P 500 P/E ratio of 17.7. Shares are up 0.5% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Aetna Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Micron Shares Tumble on Mixed Earnings Results

Micron Shares Tumble on Mixed Earnings Results

Tuesday Turnaround: Fed Up With the Fed Yet?

Tuesday Turnaround: Fed Up With the Fed Yet?

What Is Litecoin? What to Know in 2019

What Is Litecoin? What to Know in 2019

Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading

Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading

Fed Seen Likely to Raise Rates as Stocks Reel, Trump Rants

Fed Seen Likely to Raise Rates as Stocks Reel, Trump Rants